Japan's day, wrapped and delivered by morning.
Latest Tokyo Brief coverage on Convano Inc., tracking filings, financial news, and market signals from Japan.
TSE:6574
A ¥900mn, self-funded share purchase priced at ¥20 apiece hands Convano a controlling 68.90% stake in Growth Market-listed Axel Mark, with an explicit mandate to build up the target's healthcare business.
Convano's corrected results for the year to March 2026 cut revenue to ¥15.44 billion from ¥15.50 billion, operating profit to ¥1.484 billion from ¥1.795 billion and widened the loss attributable to owners to ¥1.178 billion from ¥951 million. A review of expense classification, the treatment of 10 million subsidiary-held shares as treasury stock and a tax-related correction all fed into the reset. The yen guidance for next year stayed in place, but forecast EPS fell to ¥11.67 from ¥12.25.